D-Wave Quantum receives non-compliance notice from NYSE

D-Wave Quantum announced that it received notice from the New York Stock Exchange on October 20, 2023 that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because, as of October 20, 2023, the average closing price of the company’s common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company’s common stock from the NYSE. On October 24, 2023, the company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. The company can regain compliance at any time within the six-month period following receipt of the NYSE notice if on the last trading day of any calendar month during the cure period the company has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. Under the NYSE’s rules, if the company determines that, if necessary, it will cure the stock price deficiency by taking an action that will require stockholder approval, it must so inform the NYSE in the above referenced notification and the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price remains above that level for at least the following 30 trading days. The company intends to consider available alternatives, including but not limited to a reverse stock split, that are subject to shareholder approval.